SyQ58676
a_WP-BKGD-FZ03

Immunization

Immunization

General instructions for vaccinations

Any vaccine can be given with another

  • Mild illness is not a contraindication for vaccination
  • Inactivated vaccines are generally acceptable (e.g. Pneumococcal, Meningococcal and influenza (trivalent inactivated Influenza vaccine) and live vaccines generally are avoided in persons with immune deficiencies or immune suppressive conditions. Information on specific conditions is available at the site mentioned (see Appendix I).
  • Clinically significant adverse events that follow immunization should be reported through Adverse Drug Reaction (ADR) reporting system.
  • Events or conditions listed as precautions should be reviewed carefully. Benefits and risks of administering a specific vaccine to a person under these circumstances should be considered. If the risk from the vaccine is believed to outweigh the benefit, the vaccine should not be administered. If the benefit of vaccination is believed to outweigh the risk, the vaccine should be administered.
  • For those who fall behind the recommended immunization schedule or start late, refer to the catch up schedule available at the site already mentioned (refer to Appendix III, VI, V, VI, VII).

Definitions

Contraindication –– A contraindication is a condition in a recipient that increases the risk for a serious adverse reaction. A vaccine will not be administered when a contraindication is present.

Precaution –– A precaution is a condition in a recipient that might increase the risk for a serious adverse reaction or that might compromise the ability of the vaccine to produce immunity.

Immunosuppressive therapy Substantially immunosuppressive steroid dose is considered to be two weeks or more of daily receipt of 20 mg or more (or 2mg/kg body weight or more) of Prednisolone or equivalent.

NB.

  • For programmed more details on immunization refer to Appendix III.
  • For more details on immunization refer to Appendix II, i.e. Summary of Recommendations for Adult Immunization.
  • For complete statements by the Advisory Committee on Immunization Practices (ACIP),
    visit www.cdc.gov/vaccines/pubs/ACIP-list.htm.

Created by: Dr Farouq Al-Zurba


 PO Box 80039 | KO Bahrain | Tel: +973 17484131 | Mobile: +973 39602422 http://twitter.com/fzurba | http://www.facebook.com/farouq.alzurba